Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

LATE-BREAKING ABSTRACT: Human mesenchymal stem cell exosomes attenuates sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway

Jie Chen, Liangan Chen
European Respiratory Journal 2015 46: OA4471; DOI: 10.1183/13993003.congress-2015.OA4471
Jie Chen
Department of Respiratory Medicine, Chinese People's Liberation Army General Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liangan Chen
Department of Respiratory Medicine, Chinese People's Liberation Army General Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background and objectives: Acute lung injury (ALI) secondary to sepsis is a complex syndrome associated with high morbidity and mortality. Mesenchymal stem cells (MSCs) or its conditioned medium were demonstrated to reduce alveolar inflammation, improve lung endothelial barrier permeability and modulate the oxidative stress in vivo and in vitro. Recently, MSCs were found to release exosomes that could deliver proteins, bio-active lipids and nucleic acids to injured cells. The current study was designed to determine if exosomes released by MSCs would be effective in sepsis-induced ALI mice and the potential mechanisms.

Methods and results: After six hours of cecal ligation and puncture (CLP), mice received saline, exosomes-depleted conditioned media (ExD-CM) or exosomes via the tail vein. Exosomes administration not only improved pulmonary microvascular permeability, but also inhibited histopathological changes and infiltration of polymorphonuclear granulocytes into lung tissues. In addition, activities of anti-oxidant enzymes such as superoxide dismutase, catalase and glutathione peroxidase and lipid peroxidation were significantly increased in the exosomes group versus the saline and ExD-CM groups. Furthermore, exosomes suppressed phosphorylation of NF-κB and MAPK and degradation of IκB, an NF-κB inhibitor. Decreased activities of nuclear factor-erythroid-2-related-factor-2 and heme oxygenase-1 caused by sepsis were reversed by exosomes.

Conclusions: Those findings suggest that one of the protective mechanisms of exosomes on sepsis-induced ALI is throughupregulation of antioxidative enzymes and inhibition of MAPK-NF-κB activation.

  • Acute respiratory failure
  • ARDS (Acute Respiratory Distress Syndrome)
  • Molecular pathology
  • Copyright ©ERS 2015
Previous
Back to top
Vol 46 Issue suppl 59 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
LATE-BREAKING ABSTRACT: Human mesenchymal stem cell exosomes attenuates sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
LATE-BREAKING ABSTRACT: Human mesenchymal stem cell exosomes attenuates sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway
Jie Chen, Liangan Chen
European Respiratory Journal Sep 2015, 46 (suppl 59) OA4471; DOI: 10.1183/13993003.congress-2015.OA4471

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
LATE-BREAKING ABSTRACT: Human mesenchymal stem cell exosomes attenuates sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway
Jie Chen, Liangan Chen
European Respiratory Journal Sep 2015, 46 (suppl 59) OA4471; DOI: 10.1183/13993003.congress-2015.OA4471
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Acquired coagulation disorders during extracorporeal carbon dioxide removal
  • Aggressive treatment of simple pleural effusion in ventilated patients: Pigtail catheters versus thoracostomy
  • Effect of non-patient-level factors on mortality in intensive care units
Show more 2.1 Acute Critical Care

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society